Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple, and complete. | Roche provides innovative healthcare solutions focused on testing efficiency and medical value to face the challenges of today even as we anticipate the needs of tomorrow. Genentech, now a member of the Roche Group, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with life-threatening diseases.
RhoDx
Powering the Future of Liquid Biopsy RhoDx is dedicated to unleashing the power of liquid biopsy to fight cancer. Our cell free DNA/RNA enrichment technologies deliver transformative improvements in performance and efficiency to ensure liquid biopsy will be an accessible and effective weapon against cancer. RhoDx’s PointSuppressor (PSP) suppresses wild-type DNA background before you sequence-delivering clearer mutant calls, higher detection sensitivity, and dramatically lower NGS costs. PointSuppressor doesn’t require blockers or allele-specific primers, and because the method stays single-tube, it integrates seamlessly with Lynx automation. No extra steps. No sample loss.
Revvity Health Sciences, Inc.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments. Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.
REPROCELL/BioServe
REPROCELL is a global leader providing researchers with integrated tools for translational research including biospecimens, molecular biology services, iPSC, CRISPR, human fresh tissue assays and 3D cell culture. For oncology researchers we have a large inventory of cancer tissues and biofluids, DNA/RNA, matched sample sets, samples with mutation information and can perform drug toxicity (IC50) analysis for compounds of interest using normal and cancer cell lines.
Quantum-Si
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com | Quantum-Si is redefining proteomic analysis by making single molecule protein analysis fast, simple, and accessible to every lab, everywhere. Powered by our core technology, Next-Gen Protein Sequencing™, Quantum-Si’s single-molecule platform enables kinetic measurements, revealing not just which proteins are present, but how they behave and interact within biological systems. By removing the complexity of traditional workflows like gels, Western blots, or specialized core facilities, Quantum-Si brings powerful, quantitative proteomic capabilities directly to the benchtop. It’s a new approach to protein analysis, one that provides both identification and quantitative understanding in a single platform with unparalleled resolution. With Quantum-Si, researchers gain deeper clarity into the molecular mechanisms that shape life, and the human condition. This advancement supports a new era of functional proteomics, accelerating discoveries across research, therapeutic development, and beyond.
Pythia Biosciences
Pythia BioSciences accelerates discoveries in life sciences with high-quality curated omics data, intelligent analytics platforms and cutting-edge services.
Psomagen
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Proteome Sciences US Inc
Proteome Sciences is a CRO specialising in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterise proteins and their associated post translational modifications. By using LC-MS2, SysQuant® and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment. These key protein biomarkers can then be measured in a GCLP accredited Targeted Assay in a clinical trial, via a multiplexed assay of up to 100 proteins/sample. New! We now offer Single Cell Proteome analysis. New! We have just opened a full service lab in San Diego! New! New services based on TMT-32 plex available now!
PROMEGA
Promega designs and manufactures assays, reagents and instrumentation for cellular biology, protein analysis and genomics to advance life science discovery.
PredxBio
PredxBio is a clinical decision intelligence company advancing oncology drug development through AI-driven tissue intelligence. Its proprietary SpaceIQ™ platform decodes the spatial architecture of the tumor microenvironment by integrating multiplex tissue imaging, spatial multi-omic data, and explainable AI. SpaceIQ™ converts complex spatial tissue data into reproducible, mechanistic biomarkers and decision-ready insights that guide patient stratification, clinical trial design, and program-level development decisions. By linking spatial tissue patterns to therapeutic response, PredxBio helps biopharma teams better understand mechanism of action, identify the right patient populations, and reduce late-stage clinical failure risk. PredxBio collaborates with leading pharmaceutical companies and academic cancer centers to accelerate precision oncology programs and unlock the full potential of spatial biology.